Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
The Impact of the Failure: HSBC’s Acquisition of SVB UK may offer New Opportunities for Biotech
Editorial Team
-
March 31, 2023
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical Cancer
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial
Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past
Oral Developability Assessment and Manufacturing Solution may Advance Targeted Protein Degraders
FEATURED
Why Do Politicians Weaponize Medicare? Because It Works!
Julie Rovner
-
February 21, 2023
Theranostics Has the Potential to Transform Cancer Diagnosis and Treatment
Jamie McCoy
-
February 21, 2023
My Latest Epitaph: Processing A Second Cancer Diagnosis
Bradley W. Buchanan
-
February 20, 2023
Your Money or Your Life: Patient on $50,000-a-Week Cancer Drug Fears Huge Medical Debt
Fred Schulte
-
February 16, 2023
Liquid Biopsy: Unlocking New Insights to Help Improve Outcomes for Cancer Patients
Craig Eagle, MD
-
February 15, 2023
CAR T-Cell Cancer Immunotherapy Gets Personal
Benjamin Boettner, Ph.D.
-
February 10, 2023
Keeping Up with the Complexity of Compliance in Employee Health Benefits
Annie Bushey
-
February 8, 2023
Will Your Smartphone Be the Next Doctor’s Office?
Hannah Norman
-
February 1, 2023
Advertisement
NEWS
The Impact of the Failure: HSBC’s Acquisition of SVB UK may offer New Opportunities...
Editorial Team
-
March 31, 2023
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical Cancer
Editorial Team
-
March 30, 2023
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial
Editorial Team
-
March 30, 2023
Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past
Julie Appleby
-
March 30, 2023
Oral Developability Assessment and Manufacturing Solution may Advance Targeted Protein Degraders
Editorial Team
-
March 29, 2023
Prevention is the Best Medicine: Keeping You and Your Family Safe from Cancer
Jennifer Truscott
-
March 29, 2023
First Patient Dosed in Phase 1/1b Dose Escalation/Expansion Study of PRGN-3007 in Advanced ROR1+
Editorial Team
-
March 29, 2023
A Progress Check on Hospital Price Transparency
Michelle Andrews
-
March 29, 2023
Study Shows why Late-stage Metastatic Melanoma Resists Treatment
Editorial Team
-
March 29, 2023
Study Shows COVID-19 Vaccine Induces Strong T-cell Response in Hematology Patients
Editorial Team
-
March 28, 2023
Researchers Identify Potential Targets to Overcome Treatment Resistance in Aggressive Breast Cancer
Editorial Team
-
March 28, 2023
Researchers Find Breast Tumors of Asian, Black and White Women to have Different Cellular...
Editorial Team
-
March 27, 2023
CONFERENCE COVERAGE
Zolbetuximab Plus CAPOX Improves Survival in Select Gastric Cancers
Editorial Team
-
March 22, 2023
ASCO GU: What to Expect – Updates from the Javelin Bladder Trial
Editorial Team
-
February 13, 2023
Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patient with B-lineage ALL
Danielle Garcia
-
December 13, 2022
Blood Thinners During Pregnancy in Women with Recurrent Miscarriage and Inherited Thrombophilia
Danielle Garcia
-
December 13, 2022
Zanubrutinib Demonstrates Superior PFS versus Ibrutinib in Patients Diagnosed with r/r CLL or SLL
Danielle Garcia
-
December 13, 2022
Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® in R/R AML
Editorial Team
-
December 12, 2022
A First in Class Investigational CXCR1/2 inhibitor Demonstrates Single-agent Efficacy in MDS
Danielle Garcia
-
December 12, 2022
New Anti-mutant Calreticulin (CALR)-targeted mAb: An Important Research Milestone in MF and ET
Danielle Garcia
-
December 11, 2022
Combination Treatments in Patients with Myeloproliferative Neoplasms Reduce Burden of Disease
Danielle Garcia
-
December 10, 2022
Genetic Profiling may help Omit Radiation Therapy after Breast-conserving Surgery
Editorial Team
-
December 9, 2022
Potential Chemotherapy-free option in HER2+/HR+ mBC with Zanidatamab + Palbociclib + Fulvestrant
Editorial Team
-
December 9, 2022
Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral BC
Editorial Team
-
December 9, 2022
Advertisement
EDITORIAL
Liquid Biopsy: Unlocking New Insights to Help Improve Outcomes for Cancer Patients
Craig Eagle, MD
-
February 15, 2023
Keeping Up with the Complexity of Compliance in Employee Health Benefits
Annie Bushey
-
February 8, 2023
Project Optimus: How to Prepare for Success
Julie Bullock, Pharm.D.
-
October 21, 2022
The Dictatorship of Cancer: How to Topple it in Three – Not So Easy...
Bryan Oronsky, MD. Ph.D.
-
October 21, 2022
Using Bayesian Designs to Inform Dose Recommendations in Clinical Trials
Edward Matthews
-
August 10, 2022
An Rx for American Healthcare: More Physician Entrepreneurship
Steven J. Cyr, MD
-
June 1, 2022
ERIC ROSENTHAL REPORTS
Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
Eric T. Rosenthal
-
February 13, 2021
Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
Eric T. Rosenthal
-
March 5, 2019
EXPERT INTERVIEWS
Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...
Editorial Team
-
January 18, 2023
Susanna Greer, Ph.D.: Advancing Funding for Cutting-edge Cancer Research
Editorial Team
-
November 29, 2022
The Onco’Zine Brief: A Novel Approach to Advancing Breast Cancer Therapy
Editorial Team
-
October 26, 2022
X